Your session is about to expire
← Back to Search
Motivational Interviewing for COVID-19 Vaccination Acceptance (G2YMI Trial)
N/A
Recruiting
Led By Erica Marsh, M.D.
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at 6 months
Awards & highlights
G2YMI Trial Summary
This trial will take place in four counties in Michigan where a disproportionate burden of COVID-19 is within African Americans and Latinx communities.
Who is the study for?
This trial is for adults over 18 in Michigan, particularly from African American and Latinx communities, who are vaccinated and boosted but want to help others get vaccinated (Champions), or those unvaccinated/unboosted willing to participate. They must be able to use SMS/MMS and read/write in English or Spanish.Check my eligibility
What is being tested?
The study tests motivational interviewing via text messages and web content designed to increase COVID-19 vaccine uptake among groups facing disparities. It's based on community feedback within four Michigan counties with a history of lower vaccination rates.See study design
What are the potential side effects?
Since the intervention involves informational content rather than medical treatment, traditional side effects aren't expected. However, participants may experience discomfort or anxiety related to discussions about vaccines.
G2YMI Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline at 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Self-reported COVID-19 Vaccine uptake
Secondary outcome measures
Intention to uptake COVID-19 Vaccine
G2YMI Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Enrolled study participants receive Motivational Interviewing based SMS/MMS messages to increase COVID-19 vaccine uptake, and complete Baseline and Follow-up surveys.
Group II: ControlActive Control1 Intervention
Enrolled study participants receive a simple website and complete a Baseline and Follow-up survey, after which they will receive the interventional Motivational Interviewing based SMS/MMS messages to increase COVID-19 vaccine uptake.
Find a Location
Who is running the clinical trial?
National Institutes of Health (NIH)NIH
2,701 Previous Clinical Trials
7,506,476 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
383 Previous Clinical Trials
1,215,959 Total Patients Enrolled
University of MichiganLead Sponsor
1,797 Previous Clinical Trials
6,377,658 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am willing to complete communication training in English.I am under 18 years old.I am over 18 and have not received all my COVID-19 vaccinations or boosters.I am over 18, vaccinated, and boosted, and want to be a Champion.I cannot or do not want to receive text messages.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are currently included in this trial?
"Affirmative. The information hosted on clinicaltrials.gov states that this research study is actively seeking participants; the original post was made on July 5th 2022, while last edit happened November 29th of the same year. A total of 600 individuals are needed to be enrolled across 1 medical centre."
Answered by AI
Is this clinical trial accepting participants as of now?
"Accurate. According to information hosted on clinicaltrials.gov, the research project is currently searching for 600 participants from 1 medical centre. The trial was first publicized on July 5th 2022 and its rules were most recently updated at the end of November in that same year."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger